432 related articles for article (PubMed ID: 11567050)
1. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
[TBL] [Abstract][Full Text] [Related]
2. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
[TBL] [Abstract][Full Text] [Related]
3. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
4. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.
Morinville A; Cahill CM; Aibak H; Rymar VV; Pradhan A; Hoffert C; Mennicken F; Stroh T; Sadikot AF; O'Donnell D; Clarke PB; Collier B; Henry JL; Vincent JP; Beaudet A
J Neurosci; 2004 Jun; 24(24):5549-59. PubMed ID: 15201327
[TBL] [Abstract][Full Text] [Related]
5. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.
Ong EW; Xue L; Olmstead MC; Cahill CM
Br J Pharmacol; 2015 Jan; 172(2):615-29. PubMed ID: 24819092
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
7. Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia.
Gendron L; Lucido AL; Mennicken F; O'Donnell D; Vincent JP; Stroh T; Beaudet A
J Neurosci; 2006 Jan; 26(3):953-62. PubMed ID: 16421315
[TBL] [Abstract][Full Text] [Related]
8. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor.
Margolis EB; Fujita W; Devi LA; Fields HL
Neuropharmacology; 2017 Sep; 123():420-432. PubMed ID: 28645621
[TBL] [Abstract][Full Text] [Related]
9. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
Riba P; Ben Y; Smith AP; Furst S; Lee NM
J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
[TBL] [Abstract][Full Text] [Related]
11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats.
Han SR; Lee MK; Lim KH; Yang GY; Jeon HJ; Ju JS; Yoon YW; Kim SK; Ahn DK
Eur J Pain; 2008 Apr; 12(3):361-70. PubMed ID: 17768078
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
14. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
15. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
16. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
17. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.
Gendron L; Esdaile MJ; Mennicken F; Pan H; O'Donnell D; Vincent JP; Devi LA; Cahill CM; Stroh T; Beaudet A
Neuroscience; 2007 Jan; 144(1):263-74. PubMed ID: 17055663
[TBL] [Abstract][Full Text] [Related]
18. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
Liu JG; Prather PL
J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
[TBL] [Abstract][Full Text] [Related]
19. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
[TBL] [Abstract][Full Text] [Related]
20. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
